[
    {
        "category": "company",
        "datetime": 1743512353,
        "headline": "DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns",
        "id": 133645941,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Sands Capital, an investment management company, released its \u201cSands Capital Select Growth Fund\u201d Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth [\u2026]",
        "url": "https://finnhub.io/api/news?id=b48a59017dd12e9c177c1efa4c195c8c6e98a32c8fbb7d0a913707e5da1c0127"
    },
    {
        "category": "company",
        "datetime": 1743508800,
        "headline": "Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems",
        "id": 133645943,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "BURNABY, British Columbia, April 01, 2025--The Government of Saskatchewan expands public coverage for Dexcom Continuous Glucose Monitoring Systems.",
        "url": "https://finnhub.io/api/news?id=7f9fca4aacfd528148473d4667023476d3a27d46fc669d0b8e4d038a586eacc8"
    },
    {
        "category": "company",
        "datetime": 1743440520,
        "headline": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
        "id": 133640701,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
        "url": "https://finnhub.io/api/news?id=5cb18435ede04f6f2735d872fd612ecef3de09629588b04c99183869b77c31a6"
    },
    {
        "category": "company",
        "datetime": 1743427800,
        "headline": "DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes",
        "id": 133628095,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.",
        "url": "https://finnhub.io/api/news?id=e7f3a2fdeb4469d28849be47beed22d90075a78169bb5d09db9dc63c39b3ef88"
    },
    {
        "category": "company",
        "datetime": 1743169080,
        "headline": "Baird Q4 2024 Mid Cap Growth Strategy Commentary",
        "id": 133520803,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1363638933/image_1363638933.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -1.3%, net of fees, trailing the Russell Midcap Growth increase of +8.1%.",
        "url": "https://finnhub.io/api/news?id=4426ea82fc54b5f5cd6711ee300e3ccafa4b900c35c4097b4dd1300d6e966829"
    },
    {
        "category": "company",
        "datetime": 1743093000,
        "headline": "DexCom Inc. stock underperforms Thursday when compared to competitors",
        "id": 133497546,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Thursday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=ee0c8f65f1ae073c3dd94736d809d434ca4b6eb61b717d1ee4f495aa7af0b861"
    },
    {
        "category": "company",
        "datetime": 1743090032,
        "headline": "Dexcom rejects claims of unauthorized device changes in FDA warning letter",
        "id": 133505775,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its glucose sensors.",
        "url": "https://finnhub.io/api/news?id=4a07cc01e85ecff03ada7c03701a0f24dee3a668a266eb6de8ea3c1b349052d9"
    },
    {
        "category": "company",
        "datetime": 1743080640,
        "headline": "DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval",
        "id": 133481442,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The company response is inadequate.",
        "url": "https://finnhub.io/api/news?id=9fb63d09aa8a0b4081633a73bc8ddfe1cd8b10ab0b3cff5319a51cd73d27b110"
    },
    {
        "category": "company",
        "datetime": 1743009941,
        "headline": "DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer",
        "id": 133462446,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom (NasdaqGS:DXCM) witnessed a 4% increase in its share price over the past week, as the company announced a significant integration of its G7 Continuous Glucose Monitoring Systems with Nanowear's SimpleSense platform, which is expected to advance cardiometabolic diagnostics. This innovation, along with the appointment of Jon Coleman as the Chief Commercial Officer, potentially bolstered investor confidence. Meanwhile, broader market trends showed a slight decline in major technology...",
        "url": "https://finnhub.io/api/news?id=5977d7aef25a93615e2bc6df2e5fc699baa19f2ef50d3ff9f08c24de6bbba9e7"
    },
    {
        "category": "company",
        "datetime": 1743008340,
        "headline": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
        "id": 133497547,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=315d2f323ee828a07d49f8d73bf23c021320faccb78f6d9793e9085343b8ec9f"
    },
    {
        "category": "company",
        "datetime": 1742988702,
        "headline": "Dexcom\u2019s FDA warning letter reveals unauthorized changes to sensors",
        "id": 133458407,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, according to the warning letter.",
        "url": "https://finnhub.io/api/news?id=e8a5c64a8bc3004f7a618403eff86235997b0154e871e47ff0ef75df49142158"
    },
    {
        "category": "company",
        "datetime": 1742987820,
        "headline": "DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor",
        "id": 133448406,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage.",
        "url": "https://finnhub.io/api/news?id=f73dabb9cfdd759108768afe3163e709a487767c55d75453d76bb306cf1cf3b3"
    },
    {
        "category": "company",
        "datetime": 1742933100,
        "headline": "Dexcom Appoints Jon Coleman as Chief Commercial Officer",
        "id": 133445133,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, March 25, 2025--Dexcom Appoints Jon Coleman as Chief Commercial Officer",
        "url": "https://finnhub.io/api/news?id=b894103d8877f1fa2b75b7fc7d13d7ee21605fbcf6afdde0cc4629551e31fee6"
    },
    {
        "category": "company",
        "datetime": 1742921940,
        "headline": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
        "id": 133497548,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=f61a99431c33a9910e466b047e76c5578b3242594aa369814780259b2aa08daf"
    },
    {
        "category": "company",
        "datetime": 1742902695,
        "headline": "Dexcom COO on 15-day glucose sensor, Type 2 coverage",
        "id": 133445134,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company\u2019s glucose monitors.",
        "url": "https://finnhub.io/api/news?id=48d65a04f36c0f571abea4c15b35c47b9fa3c0388751715ac754d90b87ff11cb"
    },
    {
        "category": "company",
        "datetime": 1742835480,
        "headline": "DexCom Inc. stock outperforms competitors on strong trading day",
        "id": 133401590,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock outperforms competitors on strong trading day",
        "url": "https://finnhub.io/api/news?id=2d23e36d271ecaa0eb7403891fc6a3202feb8a3b89aa90b253e3778caf19fb3a"
    },
    {
        "category": "company",
        "datetime": 1742807445,
        "headline": "DexCom (DXCM): 3 Reasons We Love This Stock",
        "id": 133338128,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next move.",
        "url": "https://finnhub.io/api/news?id=3781ce9c064bf121677702a09894699028d09fb49b46bb0c0b1d019435b8648d"
    },
    {
        "category": "company",
        "datetime": 1742576340,
        "headline": "DexCom Inc. stock underperforms Friday when compared to competitors",
        "id": 133351043,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Friday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=d189aaa8ce051b03a6ad26b5e037a1170befe7cf13714ef2d11c112556461346"
    },
    {
        "category": "company",
        "datetime": 1742547961,
        "headline": "Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers",
        "id": 133326736,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Let\u2019s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.",
        "url": "https://finnhub.io/api/news?id=35aea9b0330b2fa00aed04ca73b9a9d65be73c2643bc35e4cfb54997a807b464"
    },
    {
        "category": "company",
        "datetime": 1742490480,
        "headline": "3 Stocks That May Be Trading Below Estimated Value In March 2025",
        "id": 133326737,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "As the U.S. stock market navigates a period of mixed performance, with major indices like the Dow Jones and S&P 500 experiencing fluctuations amid economic uncertainties and tariff concerns, investors are keenly observing potential opportunities that may arise from these volatile conditions. In this environment, identifying stocks that are trading below their estimated value can be crucial for those looking to capitalize on potential market inefficiencies while considering factors such as...",
        "url": "https://finnhub.io/api/news?id=4fe52f97df04873e83cfc46c5074e21da896d154ff19b7d9badfe4d08a2d32e7"
    },
    {
        "category": "company",
        "datetime": 1742392920,
        "headline": "Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next",
        "id": 133325408,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this.  Whatever happens, though, some stocks are still worth investing in and holding on to through market volatility.  Two excellent examples are DexCom (NASDAQ: DXCM) and Vertex Pharmaceuticals (NASDAQ: VRTX).",
        "url": "https://finnhub.io/api/news?id=989dc23fd50976f7c93b8d3b4525c25cd138e8d1acc996e1b49d20a19402920c"
    },
    {
        "category": "company",
        "datetime": 1742371200,
        "headline": "Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care",
        "id": 133238666,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "EDINBURGH, Scotland & SAN DIEGO, March 19, 2025--DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the \"Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East.\" The report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain and the United Kingdom. The findings provide valuable insi",
        "url": "https://finnhub.io/api/news?id=dfa8afe56b93d52f923624a98ab0bfeeb55710e84829db01a74873bf13f494ed"
    },
    {
        "category": "company",
        "datetime": 1742319835,
        "headline": "DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires",
        "id": 133238667,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO estimates [\u2026]",
        "url": "https://finnhub.io/api/news?id=bc217b0ee7921ffefe00e1d3a04d1e60e82f0718e53ef2fe44e90ad9117792f3"
    },
    {
        "category": "company",
        "datetime": 1742105204,
        "headline": "Abbott Laboratories Basking In A Sharp Turn In Sentiment",
        "id": 133182255,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1181343146/image_1181343146.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes. Read why ABT stock is a Hold.",
        "url": "https://finnhub.io/api/news?id=c529bffd46f67ad3b6e06aab77b7ef5ea9432c8a7274b59f030505a236cc5828"
    },
    {
        "category": "company",
        "datetime": 1741954200,
        "headline": "DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter",
        "id": 133190164,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising competition pose challenges.",
        "url": "https://finnhub.io/api/news?id=d5d19a028287e7838792063ac89f220eb01d06853b6b6254ed03021246b96c16"
    },
    {
        "category": "company",
        "datetime": 1741935600,
        "headline": "History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now",
        "id": 133168046,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367482914/image_1367482914.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Corrections often lead to robust recoveries, with historical returns averaging 25% in the year following severe volatility. Read about 10 stocks that can withstand the market swoons.",
        "url": "https://finnhub.io/api/news?id=d5ef508fb28e6154539c73563ab22a6d23ca785038333b448046189cbfe47c47"
    },
    {
        "category": "company",
        "datetime": 1741716908,
        "headline": "Analysts say Dexcom\u2019s FDA warning unlikely to impact 2025 revenue",
        "id": 133190165,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom was issued with an FDA warning letter after issues with \u201cmanufacturing processes and quality management systems.\u201d",
        "url": "https://finnhub.io/api/news?id=ebdb12d8634f3fae1d2487ad8db8092e38fbddb7e4943f704a422f05d5cddfa8"
    },
    {
        "category": "company",
        "datetime": 1741684059,
        "headline": "Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)",
        "id": 133189329,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let\u2019s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4.",
        "url": "https://finnhub.io/api/news?id=edcd17591e16f5610e0dc66a40559718f5f5035a7577f1bbbb9e78a7eaae9b27"
    },
    {
        "category": "company",
        "datetime": 1741638562,
        "headline": "Why Dexcom Is On A Six-Day Losing Spree \u2014 But This Analyst Isn't Worried",
        "id": 133190167,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.",
        "url": "https://finnhub.io/api/news?id=4ad24b8d33da5a11e5df4a33657446ac58a056f48fe356024edc496b7bd53d77"
    },
    {
        "category": "company",
        "datetime": 1741622020,
        "headline": "Top Stock Movers Now: Tesla, DexCom, Strategy, and More",
        "id": 133190168,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "U.S. equities continued their selloff on worries about the U.S economy possibly heading toward a recession.",
        "url": "https://finnhub.io/api/news?id=217c65153961488f71f76e29750ba3173339853934f241e725aa377da1faefda"
    },
    {
        "category": "company",
        "datetime": 1741616127,
        "headline": "DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter",
        "id": 133190169,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.",
        "url": "https://finnhub.io/api/news?id=4db102d49e962ed4c7aae6b2abcbd8b0a5f269f0358f7383c9b7185a38361da9"
    },
    {
        "category": "company",
        "datetime": 1741609800,
        "headline": "Dexcom Appoints Ren\u00e9e Gal\u00e1 to Board of Directors",
        "id": 133190170,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, March 10, 2025--Dexcom Appoints Ren\u00e9e Gal\u00e1 to Board of Directors",
        "url": "https://finnhub.io/api/news?id=920af111b32b43e0b8d4b565f9df1e21c77298a56c15783e9cb0f3b8eaf05e4f"
    },
    {
        "category": "company",
        "datetime": 1741589838,
        "headline": "Dexcom receives warning letter based on FDA inspections of 2 plants",
        "id": 133190171,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.",
        "url": "https://finnhub.io/api/news?id=6288b4db8ad639ac27342f1ed9259806f38aca1a14da4b75798ec9bf27efcd9a"
    },
    {
        "category": "company",
        "datetime": 1741566924,
        "headline": "DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth",
        "id": 133190172,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact its ability to produce or distribute products, they may have influenced investor sentiment. The announcement came after a quarter where DexCom reported a 7% increase in sales, though net income declined significantly alongside a reduction in earnings per share. During the past quarter, major...",
        "url": "https://finnhub.io/api/news?id=4f9803a1fb9bbf2f64c99f971bd18e36683ed89a03763958fcc7755eabe1763c"
    },
    {
        "category": "company",
        "datetime": 1741439857,
        "headline": "Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?",
        "id": 133190173,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best growth stocks under $100 to buy now. Growth stocks are shares of companies which are expected to grow their revenue and [\u2026]",
        "url": "https://finnhub.io/api/news?id=3236e1cd35592f2a8c240dfcbecb3c0740a9a8e6081ee9b77c268bcf16449e5d"
    },
    {
        "category": "company",
        "datetime": 1741435299,
        "headline": "Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop",
        "id": 133190174,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom, Inc.'s (NASDAQ:DXCM) stock price has dropped 12% in the previous week, but insiders who sold US$16m in stock...",
        "url": "https://finnhub.io/api/news?id=50beb16d936a8a143564c76646f530f8e97a99e647aaf733e1aec1a6d4c55462"
    },
    {
        "category": "company",
        "datetime": 1741387910,
        "headline": "Dexcom receives FDA warning letter for two U.S. manufacturing facilities",
        "id": 133190175,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The warning letter identified issues in manufacturing processes and quality management system at Dexcom's facilities in San Diego, California and Mesa, Arizona.  The company did not provide details about how many observations were made at the two sites, but said it does not \"expect a material impact\" from the letter to its manufacturing capacity or its sales guidance for fiscal year 2025.",
        "url": "https://finnhub.io/api/news?id=30b6b11f2d2e62db1a535729f48c6761dce7ac3bd775b7f7ef5503de8650ea29"
    },
    {
        "category": "company",
        "datetime": 1741386780,
        "headline": "DexCom Gets FDA Warning Letter After Inspections of Facilities",
        "id": 133190176,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is working on a written response.",
        "url": "https://finnhub.io/api/news?id=05f8d2446cefe928deee77fb6f710b31215a3d8e52816bb8606f9fcd32904f33"
    },
    {
        "category": "company",
        "datetime": 1741322100,
        "headline": "ClearBridge Global Growth Strategy Q4 2024 Commentary",
        "id": 133085717,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385299427/image_1385299427.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "During the fourth quarter, the ClearBridge Global Growth Strategy outperformed its MSCI ACWI benchmark. Click here to read the full commentary.",
        "url": "https://finnhub.io/api/news?id=59930a1a9918ccb79efd1b65488418aa3dd6328949c2ef1595ec3cf14694e035"
    },
    {
        "category": "company",
        "datetime": 1741107016,
        "headline": "DexCom: Valuation Does Not Factor In Slowing Growth",
        "id": 132980902,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1350499666/image_1350499666.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% growth. Learn more on DXCM stock here.",
        "url": "https://finnhub.io/api/news?id=2d21dd2b3f9f8553c7d888f827ee8b4913a43deefad1788425126629879aa697"
    },
    {
        "category": "company",
        "datetime": 1741096817,
        "headline": "Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive?",
        "id": 133190177,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...",
        "url": "https://finnhub.io/api/news?id=0f26d650690d8bfc41c4fded42266789aa5376e239f284d50fce1cfa3e41441c"
    },
    {
        "category": "company",
        "datetime": 1741094141,
        "headline": "46th Annual Raymond James Institutional Investors Conference",
        "id": 132978518,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The following slide deck was published by DexCom, Inc.",
        "url": "https://finnhub.io/api/news?id=ecde758253327b4498d4683d6c804a2b9a80f857324872a77496c0ff58b41081"
    },
    {
        "category": "company",
        "datetime": 1741093983,
        "headline": "DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript)",
        "id": 132978526,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom, Inc. (NASDAQ:DXCM) 46th Annual Raymond James Institutional Investors Conference March 4, 2025 10:25 AM ETCompany ParticipantsJereme Sylvain - Chief...",
        "url": "https://finnhub.io/api/news?id=83bd7ee585f56fe3f5817233e7d18985c48c34fff7e853f6996bba24406bd198"
    },
    {
        "category": "company",
        "datetime": 1741020900,
        "headline": "DexCom Inc. stock underperforms Monday when compared to competitors",
        "id": 132990958,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Monday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=e849847b35f0c5f03ae1e2983f8853e0c330363b2a69abfb9c186ed1071c5fc4"
    },
    {
        "category": "company",
        "datetime": 1740663000,
        "headline": "Dexcom Announces Upcoming Conference Presentation",
        "id": 133190178,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, February 27, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional Investors Conference on Tuesday, March 4th.",
        "url": "https://finnhub.io/api/news?id=28be9eb1bd106bef14c5c6802e0b1068b8de324405fd46a1242eb412857e61ed"
    },
    {
        "category": "company",
        "datetime": 1740661225,
        "headline": "Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist",
        "id": 133190179,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...",
        "url": "https://finnhub.io/api/news?id=858da64da5eb53147644b1b28208cd31e50a60ed25e0ceda43fd40556393c329"
    },
    {
        "category": "company",
        "datetime": 1740647109,
        "headline": "Reflecting On Patient Monitoring Stocks\u2019 Q4 Earnings: DexCom (NASDAQ:DXCM)",
        "id": 133190180,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let\u2019s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM).",
        "url": "https://finnhub.io/api/news?id=3e48d2d18049e1e358b275c7e2198e3164b6e899ea097ca582385560baa35738"
    },
    {
        "category": "company",
        "datetime": 1740562320,
        "headline": "Got $200? 2 Healthcare Stocks to Buy and Hold Forever",
        "id": 133190181,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions.  Here are two great examples: Bristol Myers Squibb (NYSE: BMY) and DexCom (NASDAQ: DXCM).  Developing novel medicines is risky and time-consuming, and comes with a maze of regulatory challenges.",
        "url": "https://finnhub.io/api/news?id=d23f111dc4667f10240d5d3ee383950682fde8fccb747d6d6443053baa85ff4c"
    },
    {
        "category": "company",
        "datetime": 1740486600,
        "headline": "Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors",
        "id": 133190182,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career Mr. Durso led biopharmaceutical company focused on liver disease as former CEO of Intercept Pharmaceuticals, previously oversaw multiple blockbuster franchises including cardiovascular and diabetes during 22-year tenure at Sanofi GAITHERSBURG, Md., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Altimmu",
        "url": "https://finnhub.io/api/news?id=2abf94dd80f8a693ed77e04ff1a8646ddeda72fbbad8337fb59f7c7907a6889d"
    },
    {
        "category": "company",
        "datetime": 1740388620,
        "headline": "The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic",
        "id": 133185631,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.",
        "url": "https://finnhub.io/api/news?id=a245c05ebd9131497ca48215ccb4db2bb171bd6bbe76550d8638c1d395d2542b"
    },
    {
        "category": "company",
        "datetime": 1740045600,
        "headline": "Aristotle Focus Growth Q4 2024 Commentary",
        "id": 132802605,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/165180102/image_165180102.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For Q4 2024, Aristotle Atlantic\u00e2\u0080\u0099s Focus Growth Composite posted a total return of 5.05% gross of fees, underperforming the 7.07% total return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=7a7974d6724ca3dca59a1dcb0755777fe0e585d984660622df800c8771bf154c"
    },
    {
        "category": "company",
        "datetime": 1740045600,
        "headline": "Aristotle Large Cap Growth Q4 2024 Commentary",
        "id": 132802578,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For Q4 2024, Aristotle Atlantic\u00e2\u0080\u0099s Large Cap Growth Composite posted a total return of 6.29% gross of fees, underperforming the 7.07% return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=0682376595e315b4aaa043fb1c8a03a5f04c7ca7eccb5d8e631030d9d5b6d8aa"
    },
    {
        "category": "company",
        "datetime": 1739549831,
        "headline": "Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble",
        "id": 132730248,
        "image": "",
        "related": "DXCM",
        "source": "DowJones",
        "summary": "Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble",
        "url": "https://finnhub.io/api/news?id=fa8ee0fa6728cc525afdc3c28c1574e567879cfa38b9a277011b9f4fe98d17de"
    },
    {
        "category": "company",
        "datetime": 1739482389,
        "headline": "DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript",
        "id": 132709766,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ETCompany ParticipantsSean Christensen - Vice President of Finance and...",
        "url": "https://finnhub.io/api/news?id=45a90fe810583321fee327b7896408a29052d5b5b2e06e357c9bd9b5a08f547f"
    },
    {
        "category": "company",
        "datetime": 1739467729,
        "headline": "DexCom, Inc. 2024 Q4 - Results - Earnings Call Presentation",
        "id": 132708983,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The following slide deck was published by DexCom, Inc.",
        "url": "https://finnhub.io/api/news?id=a41e8f5e42ff8de0ad5ab568ac8436af79c43291e2dc9614b66bcad6a3b26bf2"
    },
    {
        "category": "company",
        "datetime": 1738774620,
        "headline": "DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
        "id": 132590962,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=6bb36a7f835822896be97b6a774ac9092cf6b750bd4c223fe6c9d2a47a7a2a93"
    },
    {
        "category": "company",
        "datetime": 1738361947,
        "headline": "Tracking Baillie Gifford's 13F Portfolio - Q4 2024 Update",
        "id": 132507642,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1318776826/image_1318776826.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Baillie Gifford's 13F portfolio shows changes in top holdings like Amazon and NVIDIA, with increased stakes in SEA Ltd. Read more on the portfolio here.",
        "url": "https://finnhub.io/api/news?id=c24a81fd2fe77e1fb954c07094e0ab0b4ca48581de40e07f8e4651b5778626c7"
    },
    {
        "category": "company",
        "datetime": 1738305334,
        "headline": "Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4: 30 p.m. Eastern Time",
        "id": 132504021,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "SAN DIEGO - DexCom, Inc. today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday, February 13, 2025.Management will hold a...",
        "url": "https://finnhub.io/api/news?id=5cd135cc2f7a8d0b017829c21c333f6742019aa15c74b5a4643184c69d9a35f3"
    },
    {
        "category": "company",
        "datetime": 1738226043,
        "headline": "Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4: 30 p.m. Eastern Time.",
        "id": 132499247,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "DexCom, Inc. today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday, February 13, 2025. Management will hold a conference...",
        "url": "https://finnhub.io/api/news?id=34ae37d4700755c228e5771fcba6d3b983293ba0d2fffe54656fbd10e9049700"
    },
    {
        "category": "company",
        "datetime": 1737714600,
        "headline": "Baron Small Cap Fund Q4 2024 Shareholder Letter",
        "id": 132455195,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1256967959/image_1256967959.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Baron Small Cap Fund declined in the fourth quarter of 2024, trailing its benchmark, the Russell 2000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=9a240dc7775f451f0ea70b1b7f16c400a6c584b8a1421f4826ada272a6d95ddb"
    },
    {
        "category": "company",
        "datetime": 1737247557,
        "headline": "Senseonics Holdings' Metrics Potentially Highlight Launch-Driven Growth, Not Sustainability",
        "id": 132423175,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1752522235/image_1752522235.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Senseonics' stock is largely unchanged versus S&P 500 gains of 31% since my sell recommendation in August 2023. See why I rate SENS stock a strong sell.",
        "url": "https://finnhub.io/api/news?id=24314181c5c57145ad8fb35d992c48aa40797ff93607d5bb52b0ce74e9144119"
    },
    {
        "category": "company",
        "datetime": 1737132201,
        "headline": "DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback",
        "id": 132416939,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1871099613/image_1871099613.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to find out why I am neutral on DXCM.",
        "url": "https://finnhub.io/api/news?id=6032ff77e10108ff3472b3cd1d997be760ec2cb8bbd4daf6c7aa9ef21709c081"
    },
    {
        "category": "company",
        "datetime": 1737008700,
        "headline": "Next Century Growth Investors Q4 2024 Commentary",
        "id": 132404982,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305707642/image_1305707642.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "In the fourth quarter of 2024, equity markets were positive and large cap stocks generally outperformed small cap stocks. Read more here.",
        "url": "https://finnhub.io/api/news?id=73e8069e54636e4d13a9d94bc0d115cbdc6cab07173db678464c129ad714ba43"
    },
    {
        "category": "company",
        "datetime": 1736753524,
        "headline": "Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook",
        "id": 132386901,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "DexCom, Inc. today reported preliminary, unaudited results for the fourth quarter ended December 31, 2024 with total revenue of at least $1.113 billion, an increase of 8% over the fourth quarter of...",
        "url": "https://finnhub.io/api/news?id=738589e68e7b365738d9dc1a0299fda7bfb012097dde47b7b3b691beeb75ce85"
    },
    {
        "category": "company",
        "datetime": 1736411826,
        "headline": "Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market.",
        "id": 132531356,
        "image": "",
        "related": "DXCM",
        "source": "DowJones",
        "summary": "Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market.",
        "url": "https://finnhub.io/api/news?id=c8bbe022b399eb2c3d04bbc4a2495b0285e66422d917737fb161b78d61010f83"
    },
    {
        "category": "company",
        "datetime": 1736372151,
        "headline": "Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)\u2019s Earnings Miss and Competitive Challenges?",
        "id": 132349798,
        "image": "https://s.yimg.com/ny/api/res/1.2/y9em_r26FPguacO7edsZbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/06f2d8033333d33022053550faaefb56",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other NASDAQ 100 stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, recently shared his perspective on the stock [\u2026]",
        "url": "https://finnhub.io/api/news?id=68a4890a95ab107adfb836aef19a4c89040a2f6b78cd31441a97e1eed264db75"
    },
    {
        "category": "company",
        "datetime": 1736343000,
        "headline": "3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025",
        "id": 132315858,
        "image": "https://g.foolcdn.com/editorial/images/802831/a-person-looking-at-a-chart-on-their-laptop.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024.  Shares of Celsius Holdings (NASDAQ: CELH), DexCom (NASDAQ: DXCM), and Nike (NYSE: NKE) all fell by more than 30% during the year, as investors weren't thrilled with their results.  Energy drink company Celsius struggled last year as its growth rate nosedived.",
        "url": "https://finnhub.io/api/news?id=d1c7fb1537adb5f678397596718af462092afef6125a3dec49c0b7e6478eed1f"
    },
    {
        "category": "company",
        "datetime": 1736256600,
        "headline": "Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference",
        "id": 132301363,
        "image": "https://media.zenfs.com/en/business-wire.com/d1b8e0281d5cb3077c3c5014571eab55",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, January 07, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 43rd annual J.P. Morgan Healthcare Conference on January 13, 2025.",
        "url": "https://finnhub.io/api/news?id=8e694617c43e397b0d6f912f762197748bf3c2b11c8e93c0abfc1089609880dc"
    },
    {
        "category": "company",
        "datetime": 1736212505,
        "headline": "UPC: No Requirement To Disclose Commercial Information In Request To Amend Claim",
        "id": 132295727,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "In accordance with front-loaded UPC procedure, any request to amend a party's case must be made as soon as it is reasonably possible to do so. This usually means that the request must be made as soon...",
        "url": "https://finnhub.io/api/news?id=d63b7c87d2f42bc813ca1d15ff404a3f37766a5f0b5f532e740beddaa2065614"
    },
    {
        "category": "company",
        "datetime": 1736161211,
        "headline": "DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher",
        "id": 132288907,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...",
        "url": "https://finnhub.io/api/news?id=e201386681cde74639254c2d631f772808cafecbc48d5f9d20d6547bcb974737"
    },
    {
        "category": "company",
        "datetime": 1735994700,
        "headline": "These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024",
        "id": 132269440,
        "image": "https://g.foolcdn.com/editorial/images/802476/concerned-young-person-with-head-in-hands-gazing-at-a-screen.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market.  Many outliers were in the tech sector, so it's worth taking a look at the tech-heavy Nasdaq-100 index.  In order from steepest decline to narrowest, the five unloved were Intel (NASDAQ: INTC), MongoDB (NASDAQ: MDB), Biogen (NASDAQ: BIIB), DexCom (NASDAQ: DXCM), and Microchip Technology (NASDAQ: MCHP).",
        "url": "https://finnhub.io/api/news?id=bed035829621e2609feed513cbb164442c8e9a15e524bcff0f039634d6e106aa"
    },
    {
        "category": "company",
        "datetime": 1735817208,
        "headline": "Abbott, Dexcom settle glucose monitor patent lawsuits",
        "id": 132243115,
        "image": "https://imgproxy.divecdn.com/kJ1x4wrMWo_3RQkeXL6_EPXJwGbJdH6NBi7HTeEKnDI/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9BQkJPVFQtU0lHTl9TUXpFY1JwLmpwZw==.webp",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The rival companies agreed not to sue each other for the next 10 years.",
        "url": "https://finnhub.io/api/news?id=778e84ba0fe58d54e6e5bfd06bdd0b547d464b6eec1523efb9c1127c0ddfe002"
    },
    {
        "category": "company",
        "datetime": 1735742220,
        "headline": "The 5 worst performing stocks on the Nasdaq 100 in 2024",
        "id": 132229013,
        "image": "",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "AI was huge in 2024. The underperformers list reflects challenges in the other sectors.",
        "url": "https://finnhub.io/api/news?id=ee11e422fa482322dff009f83a83b7a54a09ca32b8cc5cef0442dd79a6c3994c"
    },
    {
        "category": "company",
        "datetime": 1735642829,
        "headline": "DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy",
        "id": 132214281,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "In the last year, many DexCom, Inc. ( NASDAQ:DXCM ) insiders sold a substantial stake in the company which may have...",
        "url": "https://finnhub.io/api/news?id=57b08ab1fba09d76acd8ccf20c8c279deacaf73ef98f3f8248ca68fe2c230b10"
    },
    {
        "category": "company",
        "datetime": 1735300838,
        "headline": "At US$80.57, Is DexCom, Inc. (NASDAQ:DXCM) Worth Looking At Closely?",
        "id": 132178009,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Let's talk about the popular DexCom, Inc. ( NASDAQ:DXCM ). The company's shares received a lot of attention from a...",
        "url": "https://finnhub.io/api/news?id=f466c9e8e96f0358bcb2003361caaa31a899ad62c57013b2482a274dde86c658"
    },
    {
        "category": "company",
        "datetime": 1735294260,
        "headline": "Sensus Healthcare (SRTS) Surges 7.9%: Is This an Indication of Further Gains?",
        "id": 132173665,
        "image": "https://media.zenfs.com/en/zacks.com/0e4184fbbb4bd6d414018818b3c21310",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Sensus Healthcare (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
        "url": "https://finnhub.io/api/news?id=8477af102d56a1b1b18980c6a33bf002a83544b4170ffeff43754e53367c3a72"
    },
    {
        "category": "company",
        "datetime": 1735175527,
        "headline": "Auxiliary Requests Refused Due To UPC's Strict Added Matter Requirements",
        "id": 132161567,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "In the latest decision in the DexCom vs Abbott saga at the UPC, the Paris Local Division refused DexCom's three auxiliary requests to amend on the ground of added matter. The decision sheds further...",
        "url": "https://finnhub.io/api/news?id=7f0a702d18b19cb54788a0769a8f8a377e5ccd94babcbbee4d3514c4bebc1a16"
    },
    {
        "category": "company",
        "datetime": 1735139722,
        "headline": "Abbott, DexCom settlement \u2018not a complete surprise,\u2019 says Wells Fargo",
        "id": 132160958,
        "image": "https://media.zenfs.com/en/tipranks_452/e1839507ce9d5542b9a5313ac8d70b9e",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Wells Fargo notes Abbott (ABT) and DexCom (DXCM) have disclosed that on December 20, they settled and entered into a cross-license agreement to resolve all outstanding patent litigation in the U.S. and Europe for 10 years. Under the agreement, both companies granted each other worldwide royalty-free, nonexclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the litigation. The firm had expected the parties",
        "url": "https://finnhub.io/api/news?id=d11bbba0268ded74f9c3e97e1f67546f2457820ab15ffe422af3864e1a7a7c1e"
    },
    {
        "category": "company",
        "datetime": 1735122608,
        "headline": "DexCom, Abbott agree to settle patent litigation",
        "id": 132143142,
        "image": "",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "In a regulatory filing, DexCom (DXCM) stated: \u201cAs previously disclosed, DexCom has been involved in global patent litigation with Abbott (ABT) Diabetes Care and its affiliates. Both the Company and Abbott have accused the other of infringing certain patents, and each party has filed counterclaims and actions to invalidate the other party\u2019s patents. On December 20, the Company and Abbott entered into a settlement and patent cross license agreement to resolve all outstanding patent litigation betw",
        "url": "https://finnhub.io/api/news?id=3d2643186f061e7fbe7a7dbcb01895a7339d14ae89a1a4ddc5e78fd617f3e8e4"
    },
    {
        "category": "company",
        "datetime": 1735113900,
        "headline": "Carillon Eagle Mid Cap Growth Fund Q3 2024 Commentary",
        "id": 132143752,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1562199023/image_1562199023.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Mid-cap stocks improved notably during the third quarter, rebounding from the losses of the second quarter.",
        "url": "https://finnhub.io/api/news?id=ca00aa535df7587c0ee5139cba9ab6e20414fe92fc48538adfcfa42892b518fe"
    },
    {
        "category": "company",
        "datetime": 1735059780,
        "headline": "DexCom Inc. stock rises Tuesday, still underperforms market",
        "id": 132156113,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock rises Tuesday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=3fa18c17b86151a8668c03173523231aa4791b27b7f32e9aae932f129685834d"
    },
    {
        "category": "company",
        "datetime": 1735033840,
        "headline": "Abbott Agrees to Global Continuous Glucose Monitoring Litigation Settlement with Dexcom",
        "id": 132131900,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "ABBOTT PARK - Abbott announced today it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring...",
        "url": "https://finnhub.io/api/news?id=4387fc8370e01ea0d815ddf220d3e860f0773522f575b2aaef5f7b8f9be83f95"
    },
    {
        "category": "company",
        "datetime": 1735021355,
        "headline": "Wall Street Breakfast Podcast: Biden To Rule On US Steel Takeover",
        "id": 132129734,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/544455719/image_544455719.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Biden to decide on US Steel takeover after CFIUS deadlocks. Rocket Companies stock drops after CFPB sues Rocket Mortgages. Abbott in settlement with DexCom over continuous glucose monitors.",
        "url": "https://finnhub.io/api/news?id=ef34de6b558db130b0ffa53d0f92dbdef64d42773b8672ae241c20d9df336a01"
    },
    {
        "category": "company",
        "datetime": 1734990960,
        "headline": "DexCom, Abbott Agree to Settlement in Patent Litigation",
        "id": 132131224,
        "image": "",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The companies have been involved in global patent litigation, with both having accused the other of infringing certain patents, and each has filed counterclaims and actions to invalidate the other party\u2019s patents.",
        "url": "https://finnhub.io/api/news?id=68019f7210b0e223caa3d9989a99edf5c0678a372be894b5bb62d1f9e5a2a246"
    },
    {
        "category": "company",
        "datetime": 1734970380,
        "headline": "Zacks Investment Ideas feature highlights: DexCom and Albemarle",
        "id": 132123585,
        "image": "https://media.zenfs.com/en/zacks.com/b66321e586fa6fdc44309f696ff0a17a",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom and Albemarle are part of the Zacks Investment Ideas article.",
        "url": "https://finnhub.io/api/news?id=49210aa6deb11babbe848127684f67747104f055cdae078548a9104f67bd8751"
    },
    {
        "category": "company",
        "datetime": 1734953280,
        "headline": "DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?",
        "id": 132119417,
        "image": "https://media.zenfs.com/en/zacks.com/378e912f39550fd9d3e26da87fee4c8a",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.",
        "url": "https://finnhub.io/api/news?id=704566ecf65add8f500ccc230880dacfa9ce2e20864cfee6d6a9a26d9ba7d81a"
    },
    {
        "category": "company",
        "datetime": 1734948332,
        "headline": "December 2024 US Stocks Possibly Priced Below Intrinsic Value",
        "id": 132119212,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "As the United States stock market navigates a challenging landscape marked by recent losses despite encouraging inflation data, investors are keenly observing potential opportunities amid fluctuating indices. In this environment, identifying stocks that might be priced below their intrinsic value becomes crucial, as these stocks could offer long-term growth potential once market conditions stabilize.",
        "url": "https://finnhub.io/api/news?id=2b39c754b82efe057d2c83b1d501e12f35d6beed2c045315c0688852fd365151"
    },
    {
        "category": "company",
        "datetime": 1734783843,
        "headline": "DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM",
        "id": 132097922,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into DexCom, Inc. .On July...",
        "url": "https://finnhub.io/api/news?id=104756f186996d6eaa55c69b47cdba533c4ad14b43c0019fdf78a010fe1c4f51"
    },
    {
        "category": "company",
        "datetime": 1734781500,
        "headline": "1 Reason to Sell DexCom Stock, and 1 Reason to Buy",
        "id": 132097524,
        "image": "https://g.foolcdn.com/editorial/images/801479/diabetes-patient-adjusting-device.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year.  The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive drop in its stock price overnight.  On the other hand, DexCom has attractive opportunities that could allow it to deliver market-beating returns to patient investors.",
        "url": "https://finnhub.io/api/news?id=2044c9fa38793654ebf7c2cec7ad35442f326fe3eb83303567310a384bcfc2d9"
    },
    {
        "category": "company",
        "datetime": 1734699600,
        "headline": "2025 Picks: 2 Stocks to Buy Now for 50% Upside",
        "id": 132074672,
        "image": "https://media.zenfs.com/en/zacks.com/cf26e4c3a0c976d957455fdecb5b6805",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Two S&P 500 stocks--DexCom and Albemarle--are already on sale for investors to buy in 2025.",
        "url": "https://finnhub.io/api/news?id=5ba5f6a1cb88dba702f6372b06a841d0b9791be268b2b75ab820cdb2554c1c96"
    },
    {
        "category": "company",
        "datetime": 1734685746,
        "headline": "UPC Inventive Step Assessment Begins To Crystallise With Beginning Of Issuance Of Decisions",
        "id": 132073219,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "With the frequency of issuance of UPC decisions on the merits beginning to increase, the long-sought answer to the question of how the UPC will assess inventive step is beginning to form. As of yet,...",
        "url": "https://finnhub.io/api/news?id=1bd1108677dc9dba6316ed6f8f4bb1092a5146aff400d7b9a98a7932497bfa25"
    },
    {
        "category": "company",
        "datetime": 1734679414,
        "headline": "OURA Secures $200 Million in Series D Funding",
        "id": 132071655,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "SAN FRANCISCO - OURA, the company behind Oura Ring, the world's leading smart ring, today announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and...",
        "url": "https://finnhub.io/api/news?id=0774cdd98e966a4c0076917fc193dc511f204f6c1f048952a35574fc9e19aadc"
    },
    {
        "category": "company",
        "datetime": 1734540773,
        "headline": "Dexcom implements GenAI into glucose biosensor devices",
        "id": 132040598,
        "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/23/2024/12/shutterstock_1860882238.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom\u2019s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.",
        "url": "https://finnhub.io/api/news?id=7dd084e019720c91907987815b14c092ccc3450e6ca3a108758388d951db28ee"
    },
    {
        "category": "company",
        "datetime": 1734536040,
        "headline": "DXCM Stock Gains on the Launch of Proprietary Generative AI Platform",
        "id": 132040599,
        "image": "https://media.zenfs.com/en/zacks.com/e1e661692a97423f623854b9b5e54b7d",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom announces the first Generative AI platform in glucose biosensing.",
        "url": "https://finnhub.io/api/news?id=15fc76f7ea8612df326187c0f6380d7c6ec156f4f838306bc82e67747aaade0c"
    },
    {
        "category": "company",
        "datetime": 1734523629,
        "headline": "AI-Driven Glucose Biosensing: Dexcom\u2019s (DXCM) Path To A Comeback",
        "id": 132040600,
        "image": "https://media.zenfs.com/en/insidermonkey.com/ec19195fb61f45981d841fb2c1b1f851",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom has become the first company to launch a generative AI-powered continuous glucose monitor. The San Diego healthcare company announced the launch of its proprietary product after leveraging Google\u2019s Gemini models and Google\u2019s Cloud\u2019s Vertex AI platform. Dexcom is a developer and marketer of continuous glucose monitoring (CGM) systems for people with diabetes. The company [\u2026]",
        "url": "https://finnhub.io/api/news?id=d4dd216cf402d4ee5a241793b684ee19685769a0bbb58c8eb5b177f0cb912fb7"
    },
    {
        "category": "company",
        "datetime": 1734520422,
        "headline": "Dexcom adds generative AI to over-the-counter CGMs",
        "id": 132040601,
        "image": "https://imgproxy.divecdn.com/bS0sVN_qtkC9_j3-ZKDwoxsUTafoGiOSixDRnHN4pps/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TdGVsb19HYXJkZW5pbmcuanBn.webp",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom this week began rolling out the feature, which analyzes data to provide personalized tips and recommendations.",
        "url": "https://finnhub.io/api/news?id=7be1b76daa960b0407a7300439e584e7fdfb49df10400ef103140b3b24f73e24"
    },
    {
        "category": "company",
        "datetime": 1734518067,
        "headline": "Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM",
        "id": 132039403,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "BURNABY, British Columbia - Dexcom, Inc. , a global leader in glucose biosensing technology, is proud to announce that the Dexcom G7 Continuous Glucose Monitoring System has now been added to the...",
        "url": "https://finnhub.io/api/news?id=bdce0a258eedc4cab4ab5fa677a5fc9ef441be65a7b2d9846231a37a9b6f2c60"
    },
    {
        "category": "company",
        "datetime": 1734508200,
        "headline": "Gabelli Small Cap Growth Fund Q3 2024 Commentary",
        "id": 132038368,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/809861186/image_809861186.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Gabelli Small Cap Growth Fund (class I) returned 10.42% for the third quarter of 2024. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=026cfa793435e10a90fdf4e0653ac30ee8df5ef474e5a8c64ce0a721b42933a3"
    },
    {
        "category": "company",
        "datetime": 1734485100,
        "headline": "Alger Mid Cap Growth Fund Q3 2024 Commentary",
        "id": 132035985,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1695599079/image_1695599079.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Class A shares of the Alger Mid Cap Growth Fund underperformed the Russell Midcap Growth Index during the third quarter of 2024. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=6b43637b8b1a9d38eeb600ccd7619a772ed89e7a025c6b09da2a1b983deba48e"
    },
    {
        "category": "company",
        "datetime": 1734444000,
        "headline": "Dexcom Launches the First Generative AI Platform in Glucose Biosensing",
        "id": 132027914,
        "image": "https://media.zenfs.com/en/business-wire.com/a9e9c1f79c856f2ea215ad863cc7a2ef",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, December 17, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing actionable insights to help improve metabolic health.",
        "url": "https://finnhub.io/api/news?id=8441ed4d5b9b60d44d0a4647a951afae28f6d6311ade89977d26e07c00561e68"
    },
    {
        "category": "company",
        "datetime": 1734435952,
        "headline": "Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds?",
        "id": 132027916,
        "image": "https://s.yimg.com/ny/api/res/1.2/y9em_r26FPguacO7edsZbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/06f2d8033333d33022053550faaefb56",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Dexcom, Inc. (NASDAQ:DXCM) stands against the other weight loss stocks. The Revolution in Obesity Treatment: Opportunities and Challenges of GLP-1 Medications Most people have at some [\u2026]",
        "url": "https://finnhub.io/api/news?id=35927f6285116e3019aa3b4ac097923ceb5171a62393b5811502411ef24ed51f"
    },
    {
        "category": "company",
        "datetime": 1734400200,
        "headline": "Harbor Health Care ETF Q3 2024 Commentary",
        "id": 132020728,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409850701/image_1409850701.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "During the third quarter, the Harbor Health Care ETF (\u00e2\u0080\u009cETF\u00e2\u0080\u009d) returned 9.60% (NAV), outperforming the Russell 3000\u00c2\u00ae Growth Health Care Index. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=4170fab8a787c93cbda0309d7d4d7eb3ae38786f775f93c90847393bf3611397"
    },
    {
        "category": "company",
        "datetime": 1734350100,
        "headline": "American Century Ultra Fund Q3 2024 Commentary",
        "id": 132012715,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160928890/image_1160928890.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=30d50aff6e121c21c73f070a2cf619d16f40363f6bcf0607404d1f906adf3825"
    },
    {
        "category": "company",
        "datetime": 1734349500,
        "headline": "American Century Sustainable Equity Fund Q3 2024 Commentary",
        "id": 132012610,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=9c73b49c51f9436ea245048fe6cd1fc6f65d8d22263a473edba9410186f1302e"
    },
    {
        "category": "company",
        "datetime": 1734340260,
        "headline": "Pioneer Select Mid Cap Growth Fund Q3 2024 Performance And Market Commentary",
        "id": 132011140,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2169953259/image_2169953259.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Pioneer Select Mid Cap Growth Fund\u00e2\u0080\u0099s Class Y shares returned 5.38% for the third quarter, while the Fund\u00e2\u0080\u0099s benchmark, the Russell Index, returned 6.54%.",
        "url": "https://finnhub.io/api/news?id=38eb011b723ab43c3bc40c30ba8208da56d6ed5f227f9e2957aa6bd605a9e8b9"
    },
    {
        "category": "company",
        "datetime": 1734097320,
        "headline": "TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada",
        "id": 131970206,
        "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Tandem Diabetes' t:slim X2 insulin pump is now compatible with Dexcom G7 CGM in Canada.",
        "url": "https://finnhub.io/api/news?id=9ba5a46de873065b10e84185a0c5aaae0c7c7ec7654da142ffb5d77d2e12cf8f"
    },
    {
        "category": "company",
        "datetime": 1734094560,
        "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now",
        "id": 131966573,
        "image": "https://media.zenfs.com/en/zacks.com/d9f1cdae2096f5c50faaf4204585218d",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DXCM continues to raise optimism among investors owing to its strong product portfolio.",
        "url": "https://finnhub.io/api/news?id=4fbedf42a394ba0a111cfb7cf1aeb7d42a130f3ad3717fc3cacec68361a97c56"
    },
    {
        "category": "company",
        "datetime": 1734091214,
        "headline": "Why DexCom, Inc. (NASDAQ:DXCM) Looks Like A Quality Company",
        "id": 131965654,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...",
        "url": "https://finnhub.io/api/news?id=3952854e0d2f3ce0f35f03772d7c9fa04882759ae82c5bcd1a781b68ddcd579d"
    },
    {
        "category": "company",
        "datetime": 1734083100,
        "headline": "American Century Growth Fund Q3 2024 Commentary",
        "id": 131966292,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The broad U.S. stock market posted solid gains that saw a reversal of first-half  trends. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=4ff36e88373737720c7fd00f3c4e9dd534f9310a1128306049df92336f433aad"
    },
    {
        "category": "company",
        "datetime": 1733902200,
        "headline": "Allspring Mid Cap Growth Fund Q3 2024 Commentary",
        "id": 131918822,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1430370935/image_1430370935.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The Allspring Mid Cap Growth Fund outperformed the Russell Midcap Growth Index during the third quarter of 2024. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=dbdc337914ba7ada5092954baab835b54a0e3f11259cfbd2121653067591ed27"
    },
    {
        "category": "company",
        "datetime": 1733847707,
        "headline": "Dexcom shares up as Diabetes Association updates guidelines",
        "id": 131915818,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults with type 2 diabetes who are not on insulin.",
        "url": "https://finnhub.io/api/news?id=9de4753cc237ffc11382e9804fa533d09cec37f07d98a4310db4c06769cb6080"
    },
    {
        "category": "company",
        "datetime": 1733843934,
        "headline": "DexCom: Brighter 2025 From Stelo Ramp",
        "id": 131906899,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1595115113/image_1595115113.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Click here to read.",
        "url": "https://finnhub.io/api/news?id=24e606957898d6705dd0ad9e6eb0a3685d8395d6710553a478f3365c00125b44"
    },
    {
        "category": "company",
        "datetime": 1733806980,
        "headline": "BNY Mellon Small/Mid Cap Growth Fund Q3 2024 Commentary",
        "id": 131899256,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158571591/image_1158571591.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.",
        "url": "https://finnhub.io/api/news?id=15b8b386ed3039426c4013a4ab236acfbfa303572c285c0bbd74c2bb86b194e9"
    },
    {
        "category": "company",
        "datetime": 1733743080,
        "headline": "BNY Mellon Research Growth Fund, Inc. Q3 2024 Commentary",
        "id": 131870702,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1560557977/image_1560557977.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "BNY Mellon Research Growth Fund (Class A at NAV) underperformed its benchmark, the Russell 1000\u00c2\u00ae Growth Index, during the third quarter of 2024. Read more here.",
        "url": "https://finnhub.io/api/news?id=05088be8442ea502de9d36149e0e21f874fde4e854b9a58914f1de380826f7ef"
    },
    {
        "category": "company",
        "datetime": 1733735024,
        "headline": "Tax-Loss Stocks To Sell Before Everyone Else Does",
        "id": 131869198,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1795167728/image_1795167728.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Prepare for tax-loss selling at year-end by considering selling underperforming stocks like Celanese, Walgreens, and Intel. Explore more details here.",
        "url": "https://finnhub.io/api/news?id=f1721d0d8f7ac3f6583890510ac501d4aeac1ccc40598c7bb3e71a898eb673eb"
    },
    {
        "category": "company",
        "datetime": 1733483100,
        "headline": "Columbia Select Large Cap Growth Fund Q3 2024 Commentary",
        "id": 131819379,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/174691675/image_174691675.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Columbia Select Large Cap Growth Fund Institutional Class shares returned -0.22% for Q3 2024. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=f3467f14b00e5766d13b12cd2ef84acbd85e9d51067022a1bbbcee0c0a186a64"
    },
    {
        "category": "company",
        "datetime": 1733482819,
        "headline": "Investing in DexCom (NASDAQ:DXCM) five years ago would have delivered you a 56% gain",
        "id": 131818116,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...",
        "url": "https://finnhub.io/api/news?id=1a51296f92e92c23b21fd237ce53617ef8c49edf7868e80fd2c515622ed8dc06"
    },
    {
        "category": "company",
        "datetime": 1733388000,
        "headline": "Harbor Long-Term Growers ETF Q3 2024 Commentary",
        "id": 131791416,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1034849238/image_1034849238.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The Harbor Long-Term Growers ETF underperformed the benchmark during the period. Read more here.",
        "url": "https://finnhub.io/api/news?id=ba9a336cacb13b2db5854d3a8dbd1d49ad5ea99bc4d9ac65be06f4d204fe74e8"
    },
    {
        "category": "company",
        "datetime": 1733382000,
        "headline": "11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs",
        "id": 131790774,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/76133201/image_76133201.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The Euphoria index is at record highs, indicating bullish sentiment. Check out a selection of dividend stocks that could present safety and income.",
        "url": "https://finnhub.io/api/news?id=cec27ac84161aa0524de0e51036f543f1148e1b60017ecdb66d5855a581a4033"
    },
    {
        "category": "company",
        "datetime": 1733346402,
        "headline": "Tracking Chase Coleman's Tiger Global Portfolio - Q3 2024 Update",
        "id": 131772281,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126165968/image_1126165968.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Tiger Global Management's 13F portfolio increased to $23.44B. Check out the notable increases, decreases, and new stakes of the portfolio here.",
        "url": "https://finnhub.io/api/news?id=c65eb2df00aa7a7d4877b9bb5cba9488c325cb6f10fa53d9e1bcae6cb491dbfe"
    },
    {
        "category": "company",
        "datetime": 1733331720,
        "headline": "DexCom Inc. stock rises Wednesday, still underperforms market",
        "id": 131786738,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock rises Wednesday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=849a2dd7229099df4b8dde81b0090bbb8dd89431c21098b18c3031e20aa2c7f2"
    },
    {
        "category": "company",
        "datetime": 1733329851,
        "headline": "Integra (IART) Down 1.1% Since Last Earnings Report: Can It Rebound?",
        "id": 131792770,
        "image": "https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "url": "https://finnhub.io/api/news?id=fff00e58a6b1a56624a23f6e2440e82b473e6cc3c04008f121f7f5f6a3e19636"
    },
    {
        "category": "company",
        "datetime": 1733281800,
        "headline": "Columbia Convertible Securities Fund Q3 2024 Commentary",
        "id": 131763866,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1458953243/image_1458953243.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": " Columbia Convertible Securities Fund Institutional Class shares returned 5.03% for the \nquarter ended September 30, 2024. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=0d5686d64a2c6d5e17431f34f8793bf38d96d06768fd0c6d6f598e1182cb2c46"
    },
    {
        "category": "company",
        "datetime": 1733148720,
        "headline": "3 Reasons to Buy DexCom Stock Like There's No Tomorrow",
        "id": 131742101,
        "image": "https://g.foolcdn.com/editorial/images/799007/dexcom-g6-full-family.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch.  The company's shares are down sharply year to date due to unimpressive financial results -- and some of the headwinds it has encountered are, no doubt, concerning.  The company's slower-than-expected growth in international markets in the second quarter comes to mind.",
        "url": "https://finnhub.io/api/news?id=44a9d5ef6a6761295a7034e77380ceb027a45f6b22f84597889c596a63738f53"
    },
    {
        "category": "company",
        "datetime": 1733146586,
        "headline": "ModivCare: A Complicated Tale",
        "id": 131740745,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1063745116/image_1063745116.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "ModivCare's stock plummeted due to issues with Matrix Medical and delays in contract receivable collections. Read why I maintain a Hold rating on MODV stock.",
        "url": "https://finnhub.io/api/news?id=74026310c5424e2084a0646caa715d7d3694e5e36f2c99406f6af0abd4937c94"
    },
    {
        "category": "company",
        "datetime": 1733137224,
        "headline": "The Return Trends At DexCom (NASDAQ:DXCM) Look Promising",
        "id": 131737277,
        "image": "",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...",
        "url": "https://finnhub.io/api/news?id=12d9aa143f4436559dfca55b35f9f1f55410d72cb677d54bea8f32d042adccca"
    },
    {
        "category": "company",
        "datetime": 1732899720,
        "headline": "DexCom Inc. stock outperforms competitors despite losses on the day",
        "id": 131786741,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock outperforms competitors despite losses on the day",
        "url": "https://finnhub.io/api/news?id=6f98d25fadbdb7224fbf99c63a38eb4695fbd30cfbd33af7cf552cae60c18f46"
    },
    {
        "category": "company",
        "datetime": 1732797900,
        "headline": "2 Excellent Healthcare Stocks to Hold Through the Next Decade",
        "id": 131684365,
        "image": "https://g.foolcdn.com/editorial/images/798212/diabetes-patient-adjusting-device.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Although excellent medical care is always in high demand, the healthcare sector continuously evolves.  Let's consider two that specialize in developing medical devices: DexCom (NASDAQ: DXCM) and Intuitive Surgical (NASDAQ: ISRG).  DexCom has encountered some issues lately.",
        "url": "https://finnhub.io/api/news?id=bd2fd531a87dceaafbac2939b957ad7d5b84a0d938fb6a02589dd4526142bd0f"
    },
    {
        "category": "company",
        "datetime": 1732791618,
        "headline": "DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 59% Above Its Share Price",
        "id": 131684367,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Key Insights The projected fair value for DexCom is US$124 based on 2 Stage Free Cash Flow to Equity DexCom is...",
        "url": "https://finnhub.io/api/news?id=d0b9aa008f75144697c2ce386267e0d6c28e78c5294d11ef3cbaf9368ae31660"
    },
    {
        "category": "company",
        "datetime": 1732717682,
        "headline": "Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?",
        "id": 131669719,
        "image": "https://s.yimg.com/ny/api/res/1.2/y9em_r26FPguacO7edsZbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/06f2d8033333d33022053550faaefb56",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which is driven [\u2026]",
        "url": "https://finnhub.io/api/news?id=136b574e5ce7ee34d50e6ebf0f5098ff2878fec8edc0df68e6eb3d3c47df7515"
    },
    {
        "category": "company",
        "datetime": 1732697220,
        "headline": "Invesco Discovery Mid Cap Growth Fund Q3 2024 Commentary",
        "id": 131666384,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307631/image_1367307631.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Invesco Discovery Mid Cap Growth Fund outperformed in the third quarter, extending its year-to-date outperformance of the benchmark. Read more here.",
        "url": "https://finnhub.io/api/news?id=7413aeda0be9cdfab80857cb9275410016587c15b34f68128c6817f569933225"
    },
    {
        "category": "company",
        "datetime": 1732686300,
        "headline": "Invesco Equally-Weighted S&P 500 Fund Q3 2024 Commentary",
        "id": 131663340,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1936201908/image_1936201908.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The fund\u00e2\u0080\u0099s positioning within the information technology and industrial sectors had the largest positive effect on relative return.",
        "url": "https://finnhub.io/api/news?id=1eaa728bac120999a9735daa287e77798dbdb8e9fdb2564b66fdc87f2c394ac8"
    },
    {
        "category": "company",
        "datetime": 1732684200,
        "headline": "Franklin Small-Mid Cap Growth Fund Q3 2024 Review",
        "id": 131662893,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307622/image_1367307622.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "US equities collectively finished the third quarter of 2024 with record-high performance. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=d83e78bf7280c4c104ea2b8d0a5b84cf216c1ec854e61babed6499a08d241457"
    },
    {
        "category": "company",
        "datetime": 1732657020,
        "headline": "Invesco American Franchise Fund Q3 2024 Commentary",
        "id": 131655629,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/682049968/image_682049968.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Invesco American Franchise Fund currently favors a balance of high quality companies with resilient growth and early cyclical companies with potential to benefit from lower interest rates.",
        "url": "https://finnhub.io/api/news?id=a0a53752da817cd91eeb9a3adcc1d8ca9f7f56ea34d728cc416e1dafc74310d6"
    },
    {
        "category": "company",
        "datetime": 1732632611,
        "headline": "Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term",
        "id": 131648324,
        "image": "https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=36afa1f1cc41ebb3471306b022d1833e8b9ffc8fc9e44fd80320325eef063171"
    },
    {
        "category": "company",
        "datetime": 1732624620,
        "headline": "Invesco Health Care Fund Q3 2024 Commentary",
        "id": 131646502,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
        "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185"
    },
    {
        "category": "company",
        "datetime": 1732573275,
        "headline": "DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care",
        "id": 131648326,
        "image": "https://s.yimg.com/ny/api/res/1.2/y9em_r26FPguacO7edsZbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/06f2d8033333d33022053550faaefb56",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the Wells Fargo\u2019s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against Well Fargo\u2019s other growth stocks. With the interest rate cycle kicking off in the US, stocks that are [\u2026]",
        "url": "https://finnhub.io/api/news?id=7df89962aadd46998cf97c3fffe56826a5062a15852dfb195ad3a11ce53a8bf4"
    },
    {
        "category": "company",
        "datetime": 1732461300,
        "headline": "2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest",
        "id": 131617488,
        "image": "https://g.foolcdn.com/editorial/images/798433/man-20s-30s-laptop.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock market presents if you buy and hold through bull as well as bear markets.  If you're looking for unstoppable growth stocks to buy and hold for at least three to five years, and you have $1,000 to add to your portfolio right now, here are two names you should consider.  Medical device company DexCom (NASDAQ: DXCM) specializes in the diabetes care space.",
        "url": "https://finnhub.io/api/news?id=ffd9e7b4ca92d6f9a2026e1319142c148134b21c8f99c17bad8b4fb68f15b316"
    },
    {
        "category": "company",
        "datetime": 1732287272,
        "headline": "Here\u2019s Why DexCom (DXCM) Declined In Q3",
        "id": 131566933,
        "image": "https://media.zenfs.com/en/insidermonkey.com/4c71d627871fc30b6a1611f138bf86ef",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Carillon Tower Advisers, an investment management company, released its \u201cCarillon Eagle Mid Cap Growth Fund\u201d third quarter 2024 investor letter. A copy of the letter can be downloaded here. Mid-cap stocks experienced a notable improvement in the third quarter after incurring losses in the second quarter. The Russell Midcap Growth Index (up 6.54%) underperformed the [\u2026]",
        "url": "https://finnhub.io/api/news?id=901afce5b13e1d7e79dd059d05aabb3a4157ccd9397a8b665c910a59bdf35989"
    },
    {
        "category": "company",
        "datetime": 1732284900,
        "headline": "DexCom and OURA Ink Partnership for Metabolic Health Innovation",
        "id": 131566935,
        "image": "https://media.zenfs.com/en/zacks.com/d9f1cdae2096f5c50faaf4204585218d",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall well-being.",
        "url": "https://finnhub.io/api/news?id=b4de75a58d3813bb81b88317d4fc937cd87efa43c24a9621dba20ce1bc545a15"
    },
    {
        "category": "company",
        "datetime": 1732269600,
        "headline": "Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup",
        "id": 131560976,
        "image": "https://media.zenfs.com/en/quartz.com/67ba8c731090bfc249dd53e1da3d240b",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Oura smart rings will soon be able to help users track their blood sugar levels through a new partnership with Dexcom (DXCM), the maker of the U.S.\u2019s first over-the-counter continuous glucose monitor.",
        "url": "https://finnhub.io/api/news?id=c26eca6ee19bfb3efb6edba90d58d38d521b77a4553118419115de2806aebfac"
    },
    {
        "category": "company",
        "datetime": 1732198269,
        "headline": "3 US Stocks Estimated To Be Trading At Discounts Of Up To 39.3%",
        "id": 131539078,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "As stock futures rise and major indices like the Dow Jones, S&P 500, and Nasdaq show positive movement following strong earnings reports from companies such as Nvidia, investors are keenly observing market trends. In this environment of mixed performances and record highs in cryptocurrencies like Bitcoin, identifying undervalued stocks can present opportunities for those looking to capitalize on potential discounts in the market.",
        "url": "https://finnhub.io/api/news?id=dd9a7fa423bdc33344fe6f5d23893670ef21fa4baea029e07e402f5e1536beba"
    },
    {
        "category": "company",
        "datetime": 1732183140,
        "headline": "Franklin Convertible Securities Fund Q3 2024 Commentary",
        "id": 131539355,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2143902525/image_2143902525.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Nine out of 11 sector allocations contributed to the fund\u00e2\u0080\u0099s absolute return in 3Q24, while detractors in the communication services and materials sectors had a modest impact.",
        "url": "https://finnhub.io/api/news?id=304bc155138f0106581ec29a8a62b79d6836a2ec34d08e7c09960abf9afb4f50"
    },
    {
        "category": "company",
        "datetime": 1732100400,
        "headline": "Dexcom invests $75M in \u014cura, agrees to integrate smart rings and CGMs",
        "id": 131537358,
        "image": "https://imgproxy.divecdn.com/YNC3o6JTq7aP9C_R907iIb3qk9Ps-LTyATHyFl0ls84/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8wMl9PdXJhX1JpbmdfNF9Qcm9kdWN0X0ltYWdlcnkuanBn.webp",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The partnership will support data flows that enable people who use both companies\u2019 devices to track how glucose levels affect other health metrics.",
        "url": "https://finnhub.io/api/news?id=b110fb353f68df8c88d1eafdf65e11c55f91d56dfc10ba4fa0505fa12dbdd02f"
    },
    {
        "category": "company",
        "datetime": 1732038600,
        "headline": "DexCom Pairs Its Glucose Monitor With Oura\u2019s Smart Ring",
        "id": 131494161,
        "image": "https://s.yimg.com/ny/api/res/1.2/lb4Uw9clFGtNW12FT72YEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/c6fb9ae199aa31eb7241b828c429a1b4",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor DexCom and Oura smart rings.",
        "url": "https://finnhub.io/api/news?id=016322c5601297f6ac2142351bf598e5395b83b706800f93fb7b8a2621a99661"
    },
    {
        "category": "company",
        "datetime": 1732038300,
        "headline": "DexCom Pairs Its Glucose Monitor With \u014cURA\u2019s Smart Ring",
        "id": 134147481,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Pairs Its Glucose Monitor With \u014cURA\u2019s Smart Ring",
        "url": "https://finnhub.io/api/news?id=d1a9dd1c9ab5c9b9be24b2ef910e31e83e7bb2ae2963bf95df4223bc20264ad1"
    },
    {
        "category": "company",
        "datetime": 1732032927,
        "headline": "Dexcom invests $75m in \u014cURA to forge partnership",
        "id": 131494162,
        "image": "https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/11/shutterstock_2492259191.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "\u014cURA, which is now valued at more than $5bn, is set to integrate Dexcom\u2019s glucose capabilities with the Oura ring.",
        "url": "https://finnhub.io/api/news?id=654ae3cca1e2a983300a2be6c1ab0722ccf16f2e5122f6ecb8aacd5fae4b745b"
    },
    {
        "category": "company",
        "datetime": 1732028645,
        "headline": "Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing",
        "id": 131489356,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1796947698/image_1796947698.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.",
        "url": "https://finnhub.io/api/news?id=cb70e44216c714bef8a7441b53cfd98007a91bda8cbcf528aa6a02cb47ec9023"
    },
    {
        "category": "company",
        "datetime": 1732014000,
        "headline": "Dexcom and \u014cURA Announce Strategic Partnership",
        "id": 131471938,
        "image": "https://media.zenfs.com/en/business-wire.com/965588f9e5c6f59ce41e3aec518d724a",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO & SAN FRANCISCO, November 19, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and \u014cURA, maker of the world\u2019s leading smart ring, announced today a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from Oura Ring. Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products w",
        "url": "https://finnhub.io/api/news?id=f04be10a452be41c2641b53cafffe1165195eff13e1183266656bf61f281c30e"
    },
    {
        "category": "company",
        "datetime": 1731996910,
        "headline": "Smart ring maker Oura valued at over $5 billion after Dexcom funding",
        "id": 131468088,
        "image": "",
        "related": "DXCM",
        "source": "Finnhub",
        "summary": "Medical device maker Dexcom said on Tuesday it will invest $75 million in Oura's latest funding round, valuing the smart ring maker at over $5 billion. Oura, founded in Finland in 2013,...",
        "url": "https://finnhub.io/api/news?id=c6c8e5e0b33d8eeab1ebd5f961ccc6e36c09054538b6af19f774df567840e125"
    },
    {
        "category": "company",
        "datetime": 1731949320,
        "headline": "DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains",
        "id": 131486537,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=f1e44c7f1f3d4c570e9fa20635a57a100b38305f81b0164ff9df8327e63e8145"
    },
    {
        "category": "company",
        "datetime": 1731740415,
        "headline": "What Moved Markets This Week",
        "id": 131392680,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2183551608/image_2183551608.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "The article discusses the recent performance of Wall Street, including stock market movements, economic data, and notable analyst ratings on various stocks.",
        "url": "https://finnhub.io/api/news?id=1d3ce2b19a952d6169995c7ba466e1db4d0763f7e08cd4375660d8b61295b498"
    },
    {
        "category": "company",
        "datetime": 1731690725,
        "headline": "DexCom, Inc. (DXCM): Among 12 High Growth Large Cap Stocks to Buy Now",
        "id": 131374913,
        "image": "https://s.yimg.com/ny/api/res/1.2/AF59y1_4WOSaHkOSZ9Vxjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/insidermonkey.com/f7b3d5bf0b3c5442141341e739eacff5",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly optimistic about US equities. Its portfolio managers opine that there [\u2026]",
        "url": "https://finnhub.io/api/news?id=1f5c0422747592257c33d292b7c33ed52148913a05431f55646a7eef0b23ba90"
    },
    {
        "category": "company",
        "datetime": 1731582000,
        "headline": "Dexcom Helps People With Diabetes Take the First Step to Discover What They\u2019re Made Of on World Diabetes Day",
        "id": 131347491,
        "image": "https://s.yimg.com/ny/api/res/1.2/rq26B0bvRNy98BOzXbVuZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/business-wire.com/cb882ecb980f95965149a12be43b346c",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "SAN DIEGO, November 14, 2024--This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what they\u2019re made of. This comes as global data1 shows nearly 70% of people with diabetes say they didn\u2019t know where to begin their health journey when they were first diagnosed, and nearly half said diabetes has limited their ability to pursue a passion or interest.",
        "url": "https://finnhub.io/api/news?id=9f195e0a3e0e7284921db1f12aef01a6006ec76c19b5d839ad5703257c8ab30d"
    },
    {
        "category": "company",
        "datetime": 1731414240,
        "headline": "Baird Q3 2024 Mid Cap Growth Equity Fund Commentary",
        "id": 131307419,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157585497/image_2157585497.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a positive return of +5.2%, net of fees, trailing the Russell Midcap Growth increase of +6.5%.",
        "url": "https://finnhub.io/api/news?id=a5b25b172fd69ded4c1f4c5ea64982a4f9378df0e24158bd4b779aacbff79a2a"
    },
    {
        "category": "company",
        "datetime": 1731078900,
        "headline": "1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years",
        "id": 131226866,
        "image": "https://g.foolcdn.com/editorial/images/796626/dexcom-g6-full-family.png",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "This medical device company is down but not out.",
        "url": "https://finnhub.io/api/news?id=16d97d272e63cf3654d57525d25606e798d13dbb45842cda921a98087a171278"
    },
    {
        "category": "company",
        "datetime": 1730999040,
        "headline": "DexCom Inc. stock rises Thursday, still underperforms market",
        "id": 131207004,
        "image": "",
        "related": "DXCM",
        "source": "MarketWatch",
        "summary": "DexCom Inc. stock rises Thursday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=b55b8e62590996f769d0238e14435a0ea4d7d403dc51f1920471e00d4fc0df75"
    },
    {
        "category": "company",
        "datetime": 1730966400,
        "headline": "Aristotle Focus Growth Q3 2024 Commentary",
        "id": 131153459,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305170107/image_1305170107.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For Q3 2024, Aristotle Atlantic\u00e2\u0080\u0099s Focus Growth Composite posted a total return of 2.84% gross of fees, underperforming the 3.19% total return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=93091aca45c311f2693c963741d8183c95f2a5dd709f8ac4c48e9afcaa893eda"
    },
    {
        "category": "company",
        "datetime": 1730963700,
        "headline": "Aristotle Large Cap Growth Q3 2024 Commentary",
        "id": 131152190,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1503371245/image_1503371245.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "For Q3 2024, Aristotle Atlantic\u00e2\u0080\u0099s Large Cap Growth Composite posted a total return of 1.26% gross of fees, underperforming the 3.19% return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=66a7758ae364fb7c30121e8972bba8535dfc7147b42019167e4a920e38680e12"
    },
    {
        "category": "company",
        "datetime": 1730837589,
        "headline": "Tracking Baillie Gifford's 13F Portfolio - Q3 2024 Update",
        "id": 131097686,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1318776826/image_1318776826.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Baillie Gifford's diverse $134B portfolio sees stake increases in high-growth companies like Shopify, Sea Ltd., and Microsoft.",
        "url": "https://finnhub.io/api/news?id=c96993a7b1d2b0fa30cb6bc70a29ec869fab1a199b89eea725d8f97e7d5205f4"
    },
    {
        "category": "company",
        "datetime": 1730712600,
        "headline": "Baron WealthBuilder Fund Q3 2024 Shareholder Letter",
        "id": 131053135,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1142879490/image_1142879490.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Baron WealthBuilder Fund increased in the third quarter of 2024, outperforming its benchmark, the S&P 500 Index. Click here to read more.",
        "url": "https://finnhub.io/api/news?id=0650ac16f9019b0df5f64a40049965b4e71b5c6f4dacb35394031857344efd2a"
    },
    {
        "category": "company",
        "datetime": 1730478558,
        "headline": "DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss",
        "id": 131000365,
        "image": "https://media.zenfs.com/en/insidermonkey.com/4c71d627871fc30b6a1611f138bf86ef",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its \u201cFocus Growth Strategy\u201d third quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S. equity market continued its rise to new record highs, with the S&P 500 Index increasing by 5.89% during the period. Aristotle Atlantic\u2019s Focus Growth strategy returned 2.84% [\u2026]",
        "url": "https://finnhub.io/api/news?id=4ff7b471045e1f5efc92bedbca179d99c84e9cce23d091d94b04ccccf0702b6d"
    },
    {
        "category": "company",
        "datetime": 1730314979,
        "headline": "Is DexCom, Inc. (NASDAQ:DXCM) The Worst Performing S&P 500 Stock In 2024?",
        "id": 130865326,
        "image": "https://s.yimg.com/ny/api/res/1.2/y9em_r26FPguacO7edsZbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/06f2d8033333d33022053550faaefb56",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other worst performing S&P 500 stocks in 2024. Since 2023, the market has experienced extended winning streaks, reflecting the economy\u2019s resilience. The [\u2026]",
        "url": "https://finnhub.io/api/news?id=85659e2dca303a998f1b75be99fcd87c9988bb311acbb259e58030f46a1be5ab"
    },
    {
        "category": "company",
        "datetime": 1730306644,
        "headline": "Here\u2019s Why DexCom (DXCM) Detracted in Q3",
        "id": 130872317,
        "image": "https://media.zenfs.com/en/insidermonkey.com/4c71d627871fc30b6a1611f138bf86ef",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Investment advisory firm Ithaka Group released the \u201cIthaka US Growth Strategy\u201d third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The market continued to rise, which began in late October 2023, and gained across multiple asset classes. But the portfolio underperformed in this up-market, increasing 0.4% (gross of fees) vs the R1000G increasing [\u2026]",
        "url": "https://finnhub.io/api/news?id=68fc410586140ed90342deb790a9b411254b0c72bc2e438e391d163409187847"
    },
    {
        "category": "company",
        "datetime": 1730294076,
        "headline": "Multiple Headwinds Dragged DexCom (DXCM) in Q3",
        "id": 130872318,
        "image": "https://media.zenfs.com/en/insidermonkey.com/4c71d627871fc30b6a1611f138bf86ef",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Baron Funds, an investment management company, released its \u201cBaron Asset Fund\u201d third quarter 2024 investor letter. A copy of the letter can be downloaded here. US equities ended the quarter higher for the fourth quarter in a row. The Fed\u2019s long-awaited interest rate cuts and generally positive economic data caused a significant shift from large-cap, [\u2026]",
        "url": "https://finnhub.io/api/news?id=52126b34e5e50a67bed2d62953fa8ce078a45eeb654b91d36dd7adf710ddcdcd"
    },
    {
        "category": "company",
        "datetime": 1730282940,
        "headline": "Stocks with cheap implied volatility \u2013 JPM",
        "id": 130854355,
        "image": "",
        "related": "DXCM",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=2f669b35adb7b5c9d594ea8f5e088da83230ee0e7afb366741f24c6119f57c3c"
    },
    {
        "category": "company",
        "datetime": 1730203920,
        "headline": "The Ithaka Group Q3 2024 Commentary",
        "id": 130816080,
        "image": "",
        "related": "DXCM",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=4595857220f08507cd0e70a5e6aabdf86df16daa46b22d71ab9099becd121db3"
    },
    {
        "category": "company",
        "datetime": 1730123411,
        "headline": "Here's Why DexCom (DXCM) is a Strong Momentum Stock",
        "id": 130783604,
        "image": "https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=279e92abed79dc6b72052b3a321e9877df62647b4918a852bb98bf58bca37332"
    },
    {
        "category": "company",
        "datetime": 1730120411,
        "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
        "id": 130777433,
        "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
        "url": "https://finnhub.io/api/news?id=4eccd5cce7417c8f03a32fa79e111a2889f63183ddf10730dda0be4b23170cfc"
    },
    {
        "category": "company",
        "datetime": 1729945264,
        "headline": "DexCom Third Quarter 2024 Earnings: EPS Misses Expectations",
        "id": 130749861,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom ( NASDAQ:DXCM ) Third Quarter 2024 Results Key Financial Results Revenue: US$994.2m (up 2.0% from 3Q 2023). Net...",
        "url": "https://finnhub.io/api/news?id=d29584207715c0eae587fd6534b259ff0ee8b5abbe8a691930f803872c408e76"
    },
    {
        "category": "company",
        "datetime": 1729929742,
        "headline": "Decoding DexCom Inc (DXCM): A Strategic SWOT Insight",
        "id": 130749862,
        "image": "https://media.zenfs.com/en/us.finance.gurufocus/2be8b87a8c2a27dbe6c26ee55bd80ba1",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Unveiling the Financials and Strategic Directions in DexCom's Latest 10-Q",
        "url": "https://finnhub.io/api/news?id=1f21dfc7f40a4ebaabfa468f97dfd4aacb58f021e6359c974f7a2acc70f0717f"
    },
    {
        "category": "company",
        "datetime": 1729926480,
        "headline": "J.P. Morgan Sticks to Its Hold Rating for Dexcom (DXCM)",
        "id": 130754171,
        "image": "",
        "related": "DXCM",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=939bddf996c5272fde6e16a5de66f912428de537a7c7b5e8f1af8a278fd6ab41"
    },
    {
        "category": "company",
        "datetime": 1729896300,
        "headline": "Artisan Global Opportunities Fund Q3 2024 Commentary",
        "id": 130743321,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/912015114/image_912015114.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "Our portfolio underperformed the MSCI AC World Index in Q3. Click here to read more.",
        "url": "https://finnhub.io/api/news?id=be165f967fe3e8a6544db6fd67796708e79d6d09dd2d9e63eebfe16d742fdee3"
    },
    {
        "category": "company",
        "datetime": 1729893205,
        "headline": "Why DexCom Stock Flopped on Friday",
        "id": 130749863,
        "image": "https://g.foolcdn.com/editorial/images/795422/person-in-a-lab-gazing-into-a-microscope.jpg",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.",
        "url": "https://finnhub.io/api/news?id=2ea401c7e82cbda7079d692e1e089e66789b38fcdfd2f1461e9bd0f486b937f9"
    },
    {
        "category": "company",
        "datetime": 1729887969,
        "headline": "Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch",
        "id": 130749864,
        "image": "https://media.zenfs.com/en/ibd.com/28c1964d03224cc6c2f1c107d675df19",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom stock closed in the red on Friday after the diabetes devices player beat third-quarter expectations and kept its outlook.",
        "url": "https://finnhub.io/api/news?id=b0dbdd56c7d9fe380d29a39f2ebbd4c7402d1034d14a1a23374c76417b1906ec"
    },
    {
        "category": "company",
        "datetime": 1729874400,
        "headline": "DexCom Q3 Earnings Beat Estimates on Sensor Growth, Stock Rises",
        "id": 130728997,
        "image": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DXCM's third-quarter 2024 earnings and revenues surpass expectations, fueled by global growth in CGM adoption, strong Sensor sales and expansion into new markets.",
        "url": "https://finnhub.io/api/news?id=936847381b512f3126ac4a30e572337a803b215a58833759a115f0f1407d1759"
    },
    {
        "category": "company",
        "datetime": 1729873341,
        "headline": "DexCom: Exiting The 'Expansion Phase' As Competition Intensifies",
        "id": 130731856,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1871099613/image_1871099613.jpg?io=getty-c-w1536",
        "related": "DXCM",
        "source": "SeekingAlpha",
        "summary": "DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower growth expectations. Learn more on DXCM here.",
        "url": "https://finnhub.io/api/news?id=ed929acc2dbe665ff51d763615b7fd24eb09ce9358b0d8cb8cb73f90c856090a"
    },
    {
        "category": "company",
        "datetime": 1729872309,
        "headline": "Dexcom Reverses Losses Despite A Key Exec Departure Amid Stelo Launch",
        "id": 130728998,
        "image": "https://media.zenfs.com/en/ibd.com/28c1964d03224cc6c2f1c107d675df19",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Dexcom stock reversed higher early Friday after the diabetes devices player beat third-quarter expectations and kept its outlook.",
        "url": "https://finnhub.io/api/news?id=c4a3e636cd6e8905bc003de595e5b384192b4075a638eac4617b32c3325dc420"
    },
    {
        "category": "company",
        "datetime": 1729871248,
        "headline": "Dexcom chief commercial officer to retire",
        "id": 130749866,
        "image": "https://imgproxy.divecdn.com/15ltKH3gmWME-YGetcnRZuuwAHsyr6ab6e6WSa_KpOI/g:nowe:0:14/c:400:225/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL1RlcmlfTGF3dmVyX0RleGNvbS5qcGc=.webp",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "Teri Lawver is leaving the diabetes tech company during a challenging time, with sales slowing after a salesforce restructuring.",
        "url": "https://finnhub.io/api/news?id=0fe03306158cb5b9bd72701abefb6ac1bfa844a9cbef5b51f10494bb8af353b1"
    },
    {
        "category": "company",
        "datetime": 1729867620,
        "headline": "DexCom Beats Earnings Expectations. Why the Stock Is Trading Lower.",
        "id": 130728999,
        "image": "https://s.yimg.com/ny/api/res/1.2/NyKmb.nProhsMsNaaERETA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/ed7d7f3845faae8810c795751127daf6",
        "related": "DXCM",
        "source": "Yahoo",
        "summary": "DexCom  stock was falling Friday after the maker of glucose monitoring devices reported slowing revenue in the U.S.  DexCom  reported third-quarter adjusted earnings for the period ended Sept. 30, of 45 cents a share on revenue of $994.2 million.  Despite the beat, shares of  DexCom  were down 1.3% Friday to $73.74.",
        "url": "https://finnhub.io/api/news?id=84a7bfc347244f35ebb1588b8eddc3f5d60466ac0ec7169cada72caf15674773"
    },
    {
        "category": "company",
        "datetime": 1729860000,
        "headline": "Apple reportedly tests a blood sugar app",
        "id": 130727808,
        "image": "",
        "related": "DXCM",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=50389e6c793bfd4f90a991820dc11d477fc6341899547be5764798d5ecd49da5"
    },
    {
        "category": "company",
        "datetime": 1729858860,
        "headline": "Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?",
        "id": 130725295,
        "image": "",
        "related": "DXCM",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=6d2f0ea64e136932493c23dde0de04f74f83013678e27e49351e92fcb51e3653"
    },
    {
        "category": "company",
        "datetime": 1729858260,
        "headline": "Apple tested blood-sugar app, does not plan to release, Bloomberg says",
        "id": 130725297,
        "image": "",
        "related": "DXCM",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=569358fde03200969a38b937041d8a8a28b919a6ebaa5fde598902dfbcf9f104"
    },
    {
        "category": "company",
        "datetime": 1729857600,
        "headline": "Nasdaq Up Triple Digits As Stocks Rally, Yields Cool",
        "id": 130724742,
        "image": "",
        "related": "DXCM",
        "source": "TalkMarkets",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=51aed210a13db6306fba5c6be3d2af7d0b2ef766d37f71f82b4a8fced396734d"
    }
]